As COVID-19 testing moved from being a tool for the diagnosis and treatment of disease to a surveillance strategy to a labor demand, it has become somewhat disconnected from the presence SARS-CoV-2. The stunning amounts of federal resources being poured into testing, tracing and sequencing almost assures some level of testing will persist into 2022. The spotty roll-out of vaccinations in non-urban centers, if it continues, may mean testing will be required in certain industries like food processing. Pending federal OSHA rules may require it.
It is a fluid situation for certain and defies a simple open/not open thesis applied across the testing industry. Next week, we will isolate the influencers of testing trends including policy, regulation, disease trends, among other things. Join us:
|
Wednesday, April 14th @12:30PM (Add to Outlook Calendar) Connection Details: Health Policy Subscribers CLICK HERE for event details (includes video, dial-in and materials link) (For uncooperative browsers, cut and paste: https://app.hedgeye.com/feed_items/98068?with_category=48-health-policy) Participating Dialing Instructions Toll Free: Toll: UK: 0 Confirmation Number: 13717935 |
Topics:
- Growth in EUAs for testing
- Testing channels from back-to work to symptomatic
- Massive increase in capacity via new CLIA certificates
- Application of federal resources for diagnostic and surveillance
- Various pricing impacts in trade-offs between COVID-19 and routine testing
- Data trackers to monitor trends
We look forward to seeing you.
Emily Evans
Managing Director – Health Policy
Twitter
LinkedIn
